Close

Piper Jaffray Maintains a 'Neutral' on Simcere Pharmaceutical (SCR); Raises PT & Estimates Nov 30, 2009 07:00AM
Piper Jaffray Downgrades Simcere Pharmaceutical (SCR) to Neutral; Higher Sales & Marketing Costs Sep 25, 2009 08:12AM
Piper Jaffray Upgrades Simcere Pharmaceutical (SCR) to Buy; Hearing Endu Could Be First High-Priced Cancer Therapy Reimbursed in China May 5, 2009 08:14AM
Piper Jaffray Downgrades Simcere Pharmaceutical (SCR) to Neutral Feb 11, 2009 07:57AM
Piper Jaffray Upgraded Simcere Pharmaceutical (SCR) to Buy May 9, 2008 12:08PM